Background The time-course response after a single injection of botulinum toxin (BoNT) for
post-stroke spasticity is debated. We addressed this issue by conducting a systematic review …

Spasticity is a frequent symptom in stroke, multiple sclerosis, cerebral or spinal trauma, and
cerebral palsy that affects and disables a large number of adults and children. In this review …

Objective To investigate whether extracorporeal shock wave therapy (ESWT) is noninferior
to botulinum toxin type A (BoNT-A) for the treatment of poststroke upper limb spasticity …

The persistence of neck scarring is a common concern among patients undergoing
thyroidectomy. Botulinum toxin A (BTA (Botox)) has been shown to suppress scar …

Spasticity is an important factor in designing wearable and lightweight exoskeleton
neurorehabilitation robots. The proposed study evaluates biomechanical reactions of an …

This study aims to confirm the effectiveness and safety of a prabotulinumtoxin type A
(praBTX-A) injection in patients with bruxism and masseter hypertrophy. The study included …

BACKGROUND Prabotulinumtoxin A has been shown to have efficacy for the treatment of
upper-limb spasticity and improvement of moderate to severe glabellar lines. However, the …

Background: Botulinum toxin type A (BTA) is now extensively used to address cosmetic
concerns. OnabotulinumtoxinA (ONA, Botox; Allergan Inc., Irvine, CA) received FDA …

Background Botulinum toxin (BTX) is widely used for pain control in various musculoskeletal
disorders. Objectives We evaluated the analgesic effect of botulinum toxin type A (BTX-A) in …

Myofascial pain syndrome is a common painful condition encountered in the general
population. Previous studies evaluating the efficacy of botulinum toxin for the treatment of …